AIA Challenges To Drug Patents Are Down, USPTO Finds

The U.S. Patent and Trademark Office revealed in a recent report that there has been a drop in America Invents Act petitions challenging patents covering federally approved drugs in the last...

Already a subscriber? Click here to view full article